- Home
- IDYA vs HE Comparison
IDYA vs HE Comparison
Compare IDYA & HE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IDYA
- HE
- Stock Information
- Founded
- IDYA 2015
- HE 1891
- Country
- IDYA United States
- HE United States
- Employees
- IDYA N/A
- HE N/A
- Industry
- IDYA Biotechnology: Pharmaceutical Preparations
- HE Electric Utilities: Central
- Sector
- IDYA Health Care
- HE Utilities
- Exchange
- IDYA Nasdaq
- HE Nasdaq
- Market Cap
- IDYA 2.3B
- HE 2.1B
- IPO Year
- IDYA 2019
- HE N/A
- Fundamental
- Price
- IDYA $27.16
- HE $12.31
- Analyst Decision
- IDYA Buy
- HE Hold
- Analyst Count
- IDYA 14
- HE 4
- Target Price
- IDYA $49.17
- HE $10.94
- AVG Volume (30 Days)
- IDYA 953.6K
- HE 2.3M
- Earning Date
- IDYA 11-03-2025
- HE 08-07-2025
- Dividend Yield
- IDYA N/A
- HE N/A
- EPS Growth
- IDYA N/A
- HE N/A
- EPS
- IDYA N/A
- HE N/A
- Revenue
- IDYA $7,000,000.00
- HE $3,122,881,000.00
- Revenue This Year
- IDYA $62.30
- HE $12.58
- Revenue Next Year
- IDYA $285.58
- HE $2.10
- P/E Ratio
- IDYA N/A
- HE N/A
- Revenue Growth
- IDYA N/A
- HE 2.36
- 52 Week Low
- IDYA $13.45
- HE $8.14
- 52 Week High
- IDYA $39.30
- HE $13.41
- Technical
- Relative Strength Index (RSI)
- IDYA 70.30
- HE 60.50
- Support Level
- IDYA $24.04
- HE $12.08
- Resistance Level
- IDYA $25.39
- HE $13.41
- Average True Range (ATR)
- IDYA 1.05
- HE 0.33
- MACD
- IDYA 0.16
- HE 0.01
- Stochastic Oscillator
- IDYA 99.45
- HE 46.88
About IDYA IDEAYA Biosciences Inc.
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.
About HE Hawaiian Electric Industries Inc.
Hawaiian Electric Industries is the parent company of three Hawaii-based regulated utilities and owns a 10% minority interest in Hawaii's American Savings Bank. The utilities provide electricity on the five islands of Oahu, Hawaii, Maui, Molokai, and Lanai.